Get your free email accountLog in
New drugs are making a dent against some hard-to-treat cancers, but some results raise fresh questions about whether the benefit is worth the cost.
Pharmacyclics, Inc. news and stories | Webmail | Email address | Mobile Clients
Copyright 2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Copyright © 2014 1&1 Mail & Media Inc. All rights reserved.